PH25507A - N-aryl-piperazinalkanamides usefule for improving sleep - Google Patents
N-aryl-piperazinalkanamides usefule for improving sleepInfo
- Publication number
- PH25507A PH25507A PH36714A PH36714A PH25507A PH 25507 A PH25507 A PH 25507A PH 36714 A PH36714 A PH 36714A PH 36714 A PH36714 A PH 36714A PH 25507 A PH25507 A PH 25507A
- Authority
- PH
- Philippines
- Prior art keywords
- 6alkyl
- aminocarbonyl
- optionally substituted
- piperazinalkanamides
- usefule
- Prior art date
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Photolithography (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Abstract
A chemical compound having the formula <CHEM> the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, R<1> and R<2> each independently are hydrogen or C1-6alkyl; X is C1-6alkyl, hydroxyC1-6alkyl, C1-6alkyloxyC1-6alkyl, aminocarbonyl, mono- and di(C1-6alkyl)aminocarbonyl, carboxyl, C1-6alkyloxycarbonyl, (aminocarbonyl)C1-6alkyl, Ämono- and di(C1-6alkyl)aminocarbonylÜC1-6alkyl, carboxylC1-6alkyl, (C1-6alkyloxycarbonyl)C1-6alkyl or (hydroxyC1-6alkyl)aminocarboxyl; m is 1 or 2; n is 1 to 4; Ar is optionally substituted phenyl; optionally substituted pyridinyl; optionally substituted pyrazolyl; or a radical of formula <CHEM> Q' is arylethyl, arylethenyl, aryloxymethyl, diarylmethoxy, 2,2-diarylethenyl, diarylmethylcarbonyl, arylcarbonylmethyl, mono- and diarylaminocarbonyl, diarylethyl or arylaminomethyl. Process for preparing said compounds and pharmaceutical compositions comprising them are also disclosed.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3412987A | 1987-04-01 | 1987-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH25507A true PH25507A (en) | 1991-07-24 |
Family
ID=21874492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH36714A PH25507A (en) | 1987-04-01 | 1988-03-30 | N-aryl-piperazinalkanamides usefule for improving sleep |
Country Status (21)
| Country | Link |
|---|---|
| EP (2) | EP0727421B1 (en) |
| JP (1) | JP2574377B2 (en) |
| KR (1) | KR960016539B1 (en) |
| AT (2) | ATE142627T1 (en) |
| AU (1) | AU609790B2 (en) |
| CA (1) | CA1315790C (en) |
| DE (2) | DE3856501T2 (en) |
| DK (1) | DK174878B1 (en) |
| ES (2) | ES2091183T3 (en) |
| FI (1) | FI97617C (en) |
| GR (1) | GR3020983T3 (en) |
| HK (1) | HK1006020A1 (en) |
| HU (2) | HUT57740A (en) |
| IE (1) | IE81057B1 (en) |
| IL (1) | IL85919A (en) |
| NO (1) | NO178660C (en) |
| NZ (1) | NZ223847A (en) |
| PH (1) | PH25507A (en) |
| PT (1) | PT87118B (en) |
| RU (1) | RU2014328C1 (en) |
| ZA (1) | ZA882352B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840896A (en) * | 1989-11-22 | 1998-11-24 | Janssen Pharmaceutica, N.V. | Method of preventing or limiting reperfusion damage |
| RU2093156C1 (en) * | 1989-11-22 | 1997-10-20 | Жансен Фармасетика Н.В. | L-(-)-2-(aminocarbonyl)-n-(4-amino-2,6-dichlorophenyl)-4-[5,5- -bis-(4-fluorophenyl)-pentyl]-1-piperazine acetamide, its pharmaceutically acceptable salt or hydrate, a method of its synthesis and an agent for donor heart storage |
| JP2660086B2 (en) * | 1990-07-03 | 1997-10-08 | 明治製菓株式会社 | Agent for improving brain and cardiac dysfunction |
| US5276035A (en) * | 1990-07-26 | 1994-01-04 | Novo Nordisk A/S | 1,4-disubstituted piperazines |
| NZ240863A (en) * | 1991-09-11 | 1995-04-27 | Mcneilab Inc | Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof |
| SE9202266D0 (en) * | 1992-07-31 | 1992-07-31 | Kabi Pharmacia Ab | NOVEL PIPERAZINE CARBOXAMIDES |
| ATE174913T1 (en) * | 1992-07-31 | 1999-01-15 | Bristol Myers Squibb Co | DIPHENYL OXAZOLE, THIAZOLE AND IMIDAZOLE DERIVATIVES AS ADENOSINE REUPPOST INHIBITORS |
| EP0756593B1 (en) * | 1994-04-20 | 2000-09-20 | Lonza Ag | Process for preparing 2-piperazine carboxylic acid derivatives |
| CA2234342A1 (en) * | 1997-04-10 | 1998-10-10 | Kyowa Hakko Kogyo Co., Ltd. | Pancreatitis remedy |
| WO1998057643A1 (en) * | 1997-06-16 | 1998-12-23 | Janssen Pharmaceutica N.V. | Use of draflazine-analogues for treating pain |
| UA89503C2 (en) * | 2004-09-13 | 2010-02-10 | Х. Луннбек А/С | Substituted aniline derivatives |
| WO2006074025A1 (en) | 2004-12-30 | 2006-07-13 | Janssen Pharmaceutica N.V. | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| UA108233C2 (en) | 2010-05-03 | 2015-04-10 | Fatty acid amide hydrolysis activity modulators | |
| CN110511220B (en) * | 2018-05-22 | 2022-04-01 | 上海挚盟医药科技有限公司 | P-diaminobenzene derivatives as potassium channel modulators, process for their preparation and their use in medicine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1795375A1 (en) * | 1968-09-21 | 1972-01-05 | Boehringer Mannheim Gmbh | Basic ethers and methods of making them |
| US4766125A (en) * | 1981-06-23 | 1988-08-23 | Janssen Pharmaceutica N.V. | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia |
-
1988
- 1988-03-10 NZ NZ223847A patent/NZ223847A/en unknown
- 1988-03-16 CA CA000561610A patent/CA1315790C/en not_active Expired - Lifetime
- 1988-03-29 ES ES88200587T patent/ES2091183T3/en not_active Expired - Lifetime
- 1988-03-29 EP EP96200236A patent/EP0727421B1/en not_active Expired - Lifetime
- 1988-03-29 AT AT88200587T patent/ATE142627T1/en not_active IP Right Cessation
- 1988-03-29 DE DE3856501T patent/DE3856501T2/en not_active Expired - Lifetime
- 1988-03-29 AU AU13847/88A patent/AU609790B2/en not_active Expired
- 1988-03-29 EP EP88200587A patent/EP0285219B1/en not_active Expired - Lifetime
- 1988-03-29 NO NO881407A patent/NO178660C/en not_active IP Right Cessation
- 1988-03-29 ES ES96200236T patent/ES2167510T3/en not_active Expired - Lifetime
- 1988-03-29 AT AT96200236T patent/ATE207474T1/en not_active IP Right Cessation
- 1988-03-29 DE DE3855520T patent/DE3855520T2/en not_active Expired - Lifetime
- 1988-03-30 PT PT87118A patent/PT87118B/en not_active IP Right Cessation
- 1988-03-30 KR KR1019880003493A patent/KR960016539B1/en not_active Expired - Fee Related
- 1988-03-30 IL IL85919A patent/IL85919A/en not_active IP Right Cessation
- 1988-03-30 PH PH36714A patent/PH25507A/en unknown
- 1988-03-30 DK DK198801797A patent/DK174878B1/en not_active IP Right Cessation
- 1988-03-31 FI FI881525A patent/FI97617C/en not_active IP Right Cessation
- 1988-03-31 ZA ZA882352A patent/ZA882352B/en unknown
- 1988-03-31 HU HU881601A patent/HUT57740A/en unknown
- 1988-03-31 JP JP63076629A patent/JP2574377B2/en not_active Expired - Lifetime
- 1988-03-31 IE IE98988A patent/IE81057B1/en not_active IP Right Cessation
- 1988-03-31 RU SU884355523A patent/RU2014328C1/en active
-
1995
- 1995-06-20 HU HU95P/P00287P patent/HU211129A9/en unknown
-
1996
- 1996-09-12 GR GR960402273T patent/GR3020983T3/en unknown
-
1998
- 1998-06-11 HK HK98105168A patent/HK1006020A1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT70426A (en) | Pyrazolo-pyrimidine derivatives, process for preparing them and pharmaceutical compositions containing them as active agents | |
| SG15689G (en) | Substituted acyl derivatives of 1,2,3,4-tetrahydroiso-quinoline-3-carboxylic acids,salts thereof,pharmaceutical compositions containing the derivatives or salts,and the production of the same | |
| EP0151824A3 (en) | N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives | |
| GR3020983T3 (en) | Method of improving sleep | |
| GR3004114T3 (en) | ||
| IL107961A0 (en) | Phenoxy- and phenoxyalkyl-piperidines and pharmaceutical compositions containing them | |
| HUT43051A (en) | Process for preparing pyridine-carboxylic acid derivatives and pharmaceutical compositions containing thereof as active ingredients | |
| HUT40101A (en) | Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents | |
| IE890177L (en) | Piperidinyl derivatives | |
| KR0133073B1 (en) | Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones | |
| EP0193965A3 (en) | Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them | |
| NZ233526A (en) | Pyridazine derivatives and their pharmaceutical compositions | |
| IL86846A (en) | Pharmaceutical compositions for preventing and treating heart failure containing indane or naphthalene carboxylic acids | |
| NO176608C (en) | Analogous Process for Preparation of Therapeutically Active 3-Piperidinylindazole Derivatives | |
| IL87107A0 (en) | Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| MY101628A (en) | Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them. | |
| JPS5673047A (en) | Decaprenylamine derivative | |
| EP0323604A3 (en) | A venous extensibility improving and cardiac hypertrophy suppressant agent containing a dihydropyridine compound | |
| DK158513C (en) | N- (SUBSTITUTED PHENYL) -N'-PYRIDINYLURINE INGREDIENTS, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE |